Therapeutic drug monitoring: Toward tailored dosing of adalimumab in rheumatoid arthritis.
Phase of Trial: Phase IV
Latest Information Update: 16 Sep 2014
At a glance
- Drugs Adalimumab (Primary)
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- 23 Jul 2012 Status changed from not yet recruiting to planning as reported by Netherlands Trial Register record.
- 20 Jul 2012 New trial record